SGLT2 inhibitors protect the kidney by reducing glomerular capillary HTN and hyperfiltration, limiting physical stress on the filtration barrier and albuminuria (Figure 6) [384,385]. The gene discussed is SLC5A2; the disease is hypertensive disorder.